Skip to main content

News

Press Release
09/03/2024
European Society of Cardiology Press Release  London, United Kingdom – 1 September 2024: Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when...
European Society of Cardiology Press Release  London, United Kingdom – 1 September 2024: Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when...
European Society of Cardiology...
09/03/2024
EP Lab Digest
Press Release
09/03/2024
European Society of Cardiology Press Release  Performing additional catheter ablations targeting diseased myocardium along with the standard approach of pulmonary vein isolation (PVI) to treat persistent atrial fibrillation (AF) does...
European Society of Cardiology Press Release  Performing additional catheter ablations targeting diseased myocardium along with the standard approach of pulmonary vein isolation (PVI) to treat persistent atrial fibrillation (AF) does...
European Society of Cardiology...
09/03/2024
EP Lab Digest
Press Release
09/03/2024
Medtronic Press Release  Medtronic plc, a global leader in healthcare technology, shared long-term results from the global Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Trial, reinforcing the performance and...
Medtronic Press Release  Medtronic plc, a global leader in healthcare technology, shared long-term results from the global Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Trial, reinforcing the performance and...
Medtronic Press...
09/03/2024
EP Lab Digest
Press Release
09/03/2024
European Society of Cardiology Press Release  WARSAW, Poland, Sept. 2, 2024 -- New research presented at the ESC Congress 2024 reveals that a novel artificial intelligence (AI) algorithm has significantly higher sensitivity...
European Society of Cardiology Press Release  WARSAW, Poland, Sept. 2, 2024 -- New research presented at the ESC Congress 2024 reveals that a novel artificial intelligence (AI) algorithm has significantly higher sensitivity...
European Society of Cardiology...
09/03/2024
EP Lab Digest
Press Release
09/03/2024
Anthos Therapeutics Press Release  CAMBRIDGE, MASS., September 2, 2024 – Anthos Therapeutics, Inc., a transformative, clinical-stage biopharmaceutical company developing innovative therapeutic options for the treatment of...
Anthos Therapeutics Press Release  CAMBRIDGE, MASS., September 2, 2024 – Anthos Therapeutics, Inc., a transformative, clinical-stage biopharmaceutical company developing innovative therapeutic options for the treatment of...
Anthos Therapeutics Press...
09/03/2024
EP Lab Digest
Press Release
09/03/2024
A large study increased diagnoses of atrial fibrillation, but did not have enough participants to demonstrate stroke reduction
A large study increased diagnoses of atrial fibrillation, but did not have enough participants to demonstrate stroke reduction
A large study increased...
09/03/2024
EP Lab Digest
Press Release
08/30/2024
AF prevalence expected to double in coming decades – new ESC Guidelines focus on tackling comorbidities, education for patients and families, and shared decision making
AF prevalence expected to double in coming decades – new ESC Guidelines focus on tackling comorbidities, education for patients and families, and shared decision making
AF prevalence expected to double...
08/30/2024
EP Lab Digest
Press Release
08/30/2024
Bayer Press Release WHIPPANY, N.J -- Bayer will present late-breaking Phase III data from the FINEARTS-HF trial investigating KERENDIA® (finerenone) in patients with heart failure (HF) and LVEF ≥40% (left ventricular ejection...
Bayer Press Release WHIPPANY, N.J -- Bayer will present late-breaking Phase III data from the FINEARTS-HF trial investigating KERENDIA® (finerenone) in patients with heart failure (HF) and LVEF ≥40% (left ventricular ejection...
Bayer Press Release WHIPPANY,...
08/30/2024
EP Lab Digest
Press Release
08/30/2024
Alnylam Pharmaceuticals Press Release CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced detailed results from the HELIOS-B Phase 3 study of vutrisiran, an...
Alnylam Pharmaceuticals Press Release CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced detailed results from the HELIOS-B Phase 3 study of vutrisiran, an...
Alnylam Pharmaceuticals Press...
08/30/2024
EP Lab Digest
Press Release
08/30/2024
CE mark of these next-generation cardiac imaging systems will further enable connected care along the cardiology patient journey and provide clinicians with the tools to deliver more efficient and timely care
CE mark of these next-generation cardiac imaging systems will further enable connected care along the cardiology patient journey and provide clinicians with the tools to deliver more efficient and timely care
CE mark of these next-generation...
08/30/2024
EP Lab Digest